Judit Kralovánszky

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil

Erika Hitre, Barna Budai, Vilmos Adleff et al. · Pharmacogenetics and Genomics · 2005 · 69 citations

Medicine, Genetics, Oncology +15

Putative Role of Dihydropyrimidine Dehydrogenase in the Toxic Side Effect of 5-Fluorouracil in Colorectal Cancer Patients

Csilla Katona, Judit Kralovánszky, András Rosta et al. · Oncology · 1998 · 52 citations

Medicine, Oncology, Pharmacology +13

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer

Viktor Komlósi, Erika Hitre, Éva Pap et al. · BMC Cancer · 2010 · 49 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients

Vilmos Adleff, Erika Hitre, István Köves et al. · International Journal of Cancer · 2004 · 36 citations · Full text

Medicine, Genetics, Oncology +11

The Association of Polymorphisms in 5-Fluorouracil Metabolism Genes with Outcome in Adjuvant Treatment of Colorectal Cancer

Shoaib Afzal, Milena Gusella, S⊘ren Astrup Jensen et al. · Pharmacogenomics · 2011 · 32 citations

Medicine, Genetics, Oncology +17